Skip to main content
SpringerLink
Log in

Phosphodiesterase(PDE)-Inhibitoren

  • Chapter
Anästhesie in Frage und Antwort

  • 12 Accesses

Zusammenfassung

Amrinon (Wincoram, Inocor)

  1. 1.

    ist ein Katecholamin

  2. 2.

    ist ein Glykosid

  3. 3.

    wirkt nur parenteral

  4. 4.

    erniedrigt den pulmonalarteriellen Druck

  5. 5.

    erhöht den cAMP-Spiegel

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Boldt J, Knothe C, Hempelmann G (1992) Behandlung mit PDE-Inhibitoren: Pro. Anästhesiol Intensivmed Notfallmed Schmerzther 27: 319–321

    Google Scholar 

  • Dorigo P, Santostasi G, Fraccarollo D, Maragno I (1994) Inotropic agents in development. Exp Opin Invest Drugs 3: 457–468

    Article  CAS  Google Scholar 

  • Kaufmann MA, Pargger H (1994) Role of PDE-inhibitors in acute myocardial contractile failure. Anaesth Pharmacol Rev 2: 324–331

    Google Scholar 

  • Lawson NW (1989) Use of inotropes and vasopressors. ASA Annual Refresher Course Lectures, New Orleans, # 421

    Google Scholar 

  • Löllgen H, Fahrenkrog U (1992) Behandlung mit PDE-Inhibitoren: Kontra. Anästhesiol Intensivmed Notfallmed Schmerzther 27: 322–324

    Google Scholar 

  • Muller B, Komas N, Keravis T, Lugnier C (1993) Les phosphodiestérases des nucléotides cycliques. Synthèse 9: 1335–1341

    Google Scholar 

  • Parmley WW (1987) Medical treatment of CHF: Where are we now? Circulation 4: 4–10

    Google Scholar 

  • Rutman HI, LeJemtel TH, Sonnenblick EH (1987) Newer cardiotonic agents: implications for patients with heart failure and ischaemic heart disease. J Cardiothorac Anesth 1: 59–70

    Article  PubMed  CAS  Google Scholar 

  • Smith TW (1988) Digitalis: mechanism of action and clinical use. N Engl J Med 6: 358–365

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fakultät für Klinische Medizin Mannheim, Institut für Pharmakologie und Toxikologie, Ruprecht-Karls-Universität Heidelberg, Maybachstraße 14-16, D-68169, Mannheim, Deutschland

    Priv.-Doz. Dr. med. Georg Petroianu

  2. Klinikum Stadt Hanau, Institut für Anästhesiologie und operative Intensivmedizin, Akademisches Lehrkrankenhaus, Johann-Wolfgang-Goethe-Universität Frankfurt, Leimenstraße 20, D-63450, Hanau, Deutschland

    Prof. Dr. med. Peter Michael Osswald

Authors
  1. Priv.-Doz. Dr. med. Georg Petroianu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. Peter Michael Osswald
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Petroianu, G., Osswald, P.M. (2000). Phosphodiesterase(PDE)-Inhibitoren. In: Anästhesie in Frage und Antwort. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05715-5_54

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-05715-5_54

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-66276-1

  • Online ISBN: 978-3-662-05715-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation